Should we stop "MaS"ing about with steatotic liver grafts and "MiS" out on potential donor livers?

Editorial

Narci C Teoh. J Gastroenterol Hepatol. 2012 Mar.

. 2012 Mar;27(3):422-4.

doi: 10.1111/j.1440-1746.2012.07061.x.

No abstract available

Comment on

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.
Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD; Asia-Pacific Working Party on NAFLD. Chitturi S, et al. J Gastroenterol Hepatol. 2007 Jun;22(6):778-87. doi: 10.1111/j.1440-1746.2007.05001.x. J Gastroenterol Hepatol. 2007. PMID: 17565630
Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ. de Graaf EL, et al. J Gastroenterol Hepatol. 2012 Mar;27(3):540-6. doi: 10.1111/j.1440-1746.2011.06844.x. J Gastroenterol Hepatol. 2012. PMID: 21777274